Cirrhosis Patients Experiencing ARDS Encounter Significant Challenges
-
By
-
Debbie Bunch
-
April 20, 2026
Clinical Scorecard: Cirrhosis Patients Experiencing ARDS Encounter Significant Challenges
At a Glance
| Category | Detail |
|---|
| Condition | Acute Respiratory Distress Syndrome (ARDS) in patients with cirrhosis |
| Key Mechanisms | Development of ARDS secondary to cirrhosis complications such as pneumonia, gastrointestinal bleeding, and sepsis. |
| Target Population | Patients with cirrhosis admitted to the ICU |
| Care Setting | Intensive Care Unit (ICU) |
Key Highlights
- 26.6% of cirrhosis patients in ICU developed ARDS.
- 28-day mortality rate for these patients is 75.2%.
- Severity of liver disease (MELD score) and hypoxemia (PaO₂/FiO₂ ratio) are key mortality risk factors.
- Patients admitted for acute respiratory failure have better outcomes than those with non-respiratory complications.
- Systematic screening for ARDS in cirrhosis patients could improve early treatment.
Guideline-Based Recommendations
Diagnosis
- Systematic screening for ARDS in cirrhosis patients.
Management
- Utilize lung-protective ventilation strategies for ARDS management.
Monitoring & Follow-up
- Assess severity of liver disease using MELD score and monitor PaO₂/FiO₂ ratio.
Risks
- High mortality rates associated with ARDS in cirrhosis patients.
Patient & Prescribing Data
Cirrhosis patients requiring ICU admission, particularly those with ARDS.
Early identification and management of ARDS can potentially improve outcomes.
Clinical Best Practices
- Refine prognostic assessment based on reason for ICU admission.
- Encourage early liver transplantation evaluation for high-risk patients.
Related Resources & Content
